Turning point in COVID-19 severity and fatality during the pandemic: a national cohort study in Qatar

Objective To assess the evolution of COVID-19 severity and fatality in a unique setting that consistently applied, throughout the pandemic, rigorous and standardised criteria for defining severe COVID-19 outcomes.Methods and analysis We conducted a national cohort study on 312 109 Qatari citizens to...

Full description

Saved in:
Bibliographic Details
Main Authors: Roberto Bertollini (Author), Adeel Ajwad Butt (Author), Peter Coyle (Author), Andrew Jeremijenko (Author), Anvar Hassan Kaleeckal (Author), Riyazuddin Mohammad Shaik (Author), Gheyath K Nasrallah (Author), Hadi M Yassine (Author), Mohamed H Al-Thani (Author), Zaina Al-Kanaani (Author), Mohamed Ghaith Al-Kuwari (Author), Abdullatif Al-Khal (Author), Jeremy Samuel Faust (Author), Mohammad R Hasan (Author), Hebah A Al-Khatib (Author), Asmaa A Al Thani (Author), Einas Al-Kuwari (Author), Ali Latif (Author), Hanan F Abdul-Rahim (Author), Hamad Al-Romaihi (Author)
Format: Book
Published: BMJ Publishing Group, 2023-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_58ae9660be00465e84edab94d13a7201
042 |a dc 
100 1 0 |a Roberto Bertollini  |e author 
700 1 0 |a Adeel Ajwad Butt  |e author 
700 1 0 |a Peter Coyle  |e author 
700 1 0 |a Andrew Jeremijenko  |e author 
700 1 0 |a Anvar Hassan Kaleeckal  |e author 
700 1 0 |a Riyazuddin Mohammad Shaik  |e author 
700 1 0 |a Gheyath K Nasrallah  |e author 
700 1 0 |a Hadi M Yassine  |e author 
700 1 0 |a Mohamed H Al-Thani  |e author 
700 1 0 |a Zaina Al-Kanaani  |e author 
700 1 0 |a Mohamed Ghaith Al-Kuwari  |e author 
700 1 0 |a Abdullatif Al-Khal  |e author 
700 1 0 |a Jeremy Samuel Faust  |e author 
700 1 0 |a Mohammad R Hasan  |e author 
700 1 0 |a Hebah A Al-Khatib  |e author 
700 1 0 |a Asmaa A Al Thani  |e author 
700 1 0 |a Einas Al-Kuwari  |e author 
700 1 0 |a Ali Latif  |e author 
700 1 0 |a Hanan F Abdul-Rahim  |e author 
700 1 0 |a Hamad Al-Romaihi  |e author 
245 0 0 |a Turning point in COVID-19 severity and fatality during the pandemic: a national cohort study in Qatar 
260 |b BMJ Publishing Group,   |c 2023-12-01T00:00:00Z. 
500 |a 10.1136/bmjph-2023-000479 
500 |a 2753-4294 
520 |a Objective To assess the evolution of COVID-19 severity and fatality in a unique setting that consistently applied, throughout the pandemic, rigorous and standardised criteria for defining severe COVID-19 outcomes.Methods and analysis We conducted a national cohort study on 312 109 Qatari citizens to investigate incidence of severe, critical or fatal COVID-19 classified according to the WHO criteria between 28 February 2020 and 21 April 2023. Incidence rates for severe, critical or fatal COVID-19 were estimated during the pre-omicron phase, first omicron wave, combined phases and throughout the pandemic.Results Cumulative incidence of severe, critical or fatal COVID-19 after 3.14 years of follow-up was 0.45% (95% CI 0.43% to 0.47%). Incidence rate for severe, critical or fatal COVID-19 throughout the pandemic was 1.43 (95% CI 1.35 to 1.50) per 1000 person years. In the pre-omicron phase, first omicron wave, and combined phases, it was 2.01 (95% CI 1.90 to 2.13), 3.70 (95% CI 3.25 to 4.22) and 2.18 (95% CI 2.07 to 2.30) per 1000 person years, respectively. The post-first omicron phase saw a drastic drop to 0.10 (95% CI 0.08 to 0.14) per 1000 person years, a 95.4% reduction. Among all severe, critical and fatal cases, 99.5% occurred during the primary infection. Cumulative incidence of fatal COVID-19 was 0.042% (95% CI 0.036% to 0.050%), with an incidence rate of 0.13 (95% CI 0.11 to 0.16) per 1000 person years. In the post-first omicron phase, incidence rate of fatal COVID-19 decreased by 90.0% compared with earlier stages. Both severity and fatality exhibited an exponential increase with age and a linear increase with the number of coexisting conditions.Conclusion The conclusion of the first omicron wave was a turning point in the severity of the pandemic. While vaccination and enhanced case management reduced severity gradually, the rapid accumulation of natural immunity during the first omicron wave appears to have played a critical role in driving this shift in severity. 
546 |a EN 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n BMJ Public Health, Vol 1, Iss 1 (2023) 
787 0 |n https://bmjpublichealth.bmj.com/content/1/1/e000479.full 
787 0 |n https://doaj.org/toc/2753-4294 
856 4 1 |u https://doaj.org/article/58ae9660be00465e84edab94d13a7201  |z Connect to this object online.